Author Correction: Real-world clinical utility of tumor whole-genome sequencing in solid cancers (Nature Medicine, (2026), 10.1038/s41591-026-04280-2)

Jeffrey van Putten; Petur Snaebjornsson; Linda J.W. Bosch; Roelof Koster; Paul Roepman; Joseph Usset; Mirjam C. Boelens; Tom van Wezel; Efraim H. Rosenberg; Serena Marchetti; Marieke Vollebergh; Doenja M.J. Lambregts; Lizet E. van der Kolk; Edwin Cuppen; Hilde H. Nienhuis; Kim Monkhorst

doi:10.1038/s41591-026-04379-6

Author Correction: Real-world clinical utility of tumor whole-genome sequencing in solid cancers (Nature Medicine, (2026), 10.1038/s41591-026-04280-2)

Jeffrey van Putten
, Petur Snaebjornsson
, Linda J.W. Bosch
, Roelof Koster
, Paul Roepman
, Joseph Usset
, Mirjam C. Boelens
, Tom van Wezel
, Efraim H. Rosenberg
, Serena Marchetti
, Marieke Vollebergh
, Doenja M.J. Lambregts
, Lizet E. van der Kolk
, Edwin Cuppen^*
, Hilde H. Nienhuis
, Kim Monkhorst^*

^*Corresponding author for this work

Research output: Contribution to journal › Comment/Letter to the editor › Academic › peer-review

1 Downloads (Pure)

Abstract

Correction to: Nature Medicinehttps://doi.org/10.1038/s41591-026-04280-2, published online 20 March 2026. In the version of this article initially published, due to a version error, values listed on the right-hand side of Fig. 1 were incorrect, where in the text now reading “No actionable biomarkers detected: 196,” “Actionability detected only by simulated 523-gene panel and WGS: 153” and “Actionability detected by simulated 50-/523-gene panels and WGS: 352,” the values initially read “203,” “142,” and “344,” respectively. The figure is now amended in the HTML and PDF versions of the article.

Original language	English
Article number	1555
Number of pages	1
Journal	Nature medicine
Volume	32
Issue number	4
Early online date	2 Apr 2026
DOIs	https://doi.org/10.1038/s41591-026-04379-6
Publication status	Published - Apr 2026

Access to Document

10.1038/s41591-026-04379-6Licence: CC BY

s41591-026-04379-6Final published version, 472 KBLicence: CC BY

Cite this

van Putten, J., Snaebjornsson, P., Bosch, L. J. W., Koster, R., Roepman, P., Usset, J., Boelens, M. C., van Wezel, T., Rosenberg, E. H., Marchetti, S., Vollebergh, M., Lambregts, D. M. J., van der Kolk, L. E., Cuppen, E., Nienhuis, H. H., & Monkhorst, K. (2026). Author Correction: Real-world clinical utility of tumor whole-genome sequencing in solid cancers (Nature Medicine, (2026), 10.1038/s41591-026-04280-2). Nature medicine, 32(4), Article 1555. https://doi.org/10.1038/s41591-026-04379-6

@article{1f529d03738043e0b17de99c7789d037,

title = "Author Correction: Real-world clinical utility of tumor whole-genome sequencing in solid cancers (Nature Medicine, (2026), 10.1038/s41591-026-04280-2)",

abstract = "Correction to: Nature Medicinehttps://doi.org/10.1038/s41591-026-04280-2, published online 20 March 2026. In the version of this article initially published, due to a version error, values listed on the right-hand side of Fig. 1 were incorrect, where in the text now reading “No actionable biomarkers detected: 196,” “Actionability detected only by simulated 523-gene panel and WGS: 153” and “Actionability detected by simulated 50-/523-gene panels and WGS: 352,” the values initially read “203,” “142,” and “344,” respectively. The figure is now amended in the HTML and PDF versions of the article.",

author = "\{van Putten\}, Jeffrey and Petur Snaebjornsson and Bosch, \{Linda J.W.\} and Roelof Koster and Paul Roepman and Joseph Usset and Boelens, \{Mirjam C.\} and \{van Wezel\}, Tom and Rosenberg, \{Efraim H.\} and Serena Marchetti and Marieke Vollebergh and Lambregts, \{Doenja M.J.\} and \{van der Kolk\}, \{Lizet E.\} and Edwin Cuppen and Nienhuis, \{Hilde H.\} and Kim Monkhorst",

note = "Publisher Copyright: {\textcopyright} The Author(s) 2026.",

year = "2026",

month = apr,

doi = "10.1038/s41591-026-04379-6",

language = "English",

volume = "32",

journal = "Nature medicine",

issn = "1078-8956",

publisher = "Nature Research",

number = "4",

}

van Putten, J, Snaebjornsson, P, Bosch, LJW, Koster, R, Roepman, P, Usset, J, Boelens, MC, van Wezel, T, Rosenberg, EH, Marchetti, S, Vollebergh, M, Lambregts, DMJ, van der Kolk, LE, Cuppen, E, Nienhuis, HH & Monkhorst, K 2026, 'Author Correction: Real-world clinical utility of tumor whole-genome sequencing in solid cancers (Nature Medicine, (2026), 10.1038/s41591-026-04280-2)', Nature medicine, vol. 32, no. 4, 1555. https://doi.org/10.1038/s41591-026-04379-6

Author Correction: Real-world clinical utility of tumor whole-genome sequencing in solid cancers (Nature Medicine, (2026), 10.1038/s41591-026-04280-2). / van Putten, Jeffrey; Snaebjornsson, Petur; Bosch, Linda J.W. et al.
In: Nature medicine, Vol. 32, No. 4, 1555, 04.2026.

Research output: Contribution to journal › Comment/Letter to the editor › Academic › peer-review

TY - JOUR

T1 - Author Correction

T2 - Real-world clinical utility of tumor whole-genome sequencing in solid cancers (Nature Medicine, (2026), 10.1038/s41591-026-04280-2)

AU - van Putten, Jeffrey

AU - Snaebjornsson, Petur

AU - Bosch, Linda J.W.

AU - Koster, Roelof

AU - Roepman, Paul

AU - Usset, Joseph

AU - Boelens, Mirjam C.

AU - van Wezel, Tom

AU - Rosenberg, Efraim H.

AU - Marchetti, Serena

AU - Vollebergh, Marieke

AU - Lambregts, Doenja M.J.

AU - van der Kolk, Lizet E.

AU - Cuppen, Edwin

AU - Nienhuis, Hilde H.

AU - Monkhorst, Kim

PY - 2026/4

Y1 - 2026/4

N2 - Correction to: Nature Medicinehttps://doi.org/10.1038/s41591-026-04280-2, published online 20 March 2026. In the version of this article initially published, due to a version error, values listed on the right-hand side of Fig. 1 were incorrect, where in the text now reading “No actionable biomarkers detected: 196,” “Actionability detected only by simulated 523-gene panel and WGS: 153” and “Actionability detected by simulated 50-/523-gene panels and WGS: 352,” the values initially read “203,” “142,” and “344,” respectively. The figure is now amended in the HTML and PDF versions of the article.

AB - Correction to: Nature Medicinehttps://doi.org/10.1038/s41591-026-04280-2, published online 20 March 2026. In the version of this article initially published, due to a version error, values listed on the right-hand side of Fig. 1 were incorrect, where in the text now reading “No actionable biomarkers detected: 196,” “Actionability detected only by simulated 523-gene panel and WGS: 153” and “Actionability detected by simulated 50-/523-gene panels and WGS: 352,” the values initially read “203,” “142,” and “344,” respectively. The figure is now amended in the HTML and PDF versions of the article.

UR - https://www.scopus.com/pages/publications/105034907292

U2 - 10.1038/s41591-026-04379-6

DO - 10.1038/s41591-026-04379-6

M3 - Comment/Letter to the editor

C2 - 41928039

AN - SCOPUS:105034907292

SN - 1078-8956

VL - 32

JO - Nature medicine

JF - Nature medicine

IS - 4

M1 - 1555

ER -

Author Correction: Real-world clinical utility of tumor whole-genome sequencing in solid cancers (Nature Medicine, (2026), 10.1038/s41591-026-04280-2)

Abstract

Access to Document

Other files and links

Fingerprint

Real-world clinical utility of tumor whole-genome sequencing in solid cancers

Cite this